EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Role of Transcription Factor, LIM Homeobox 9 (LHX9) in Inflammatory Response by PGE2 and Thrombin in SERPINA1‐Silencing Endometrial Stromal Cells

Kazuya Kusama iD, Misuzu Ashihara, Moana Okita, Kanoko Yoshida, Masumi Suzuki, Kaito Suzuki, Rena Hosokawa, Mikihiro Yoshie, Junya Kojima, Yumi Mizuno, Masanori Ono, Hirotaka Nishi und 2 weitere

Molecular Reproduction and Development · 2025

DOI: 10.1002/mrd.70046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Reproduction and Development, 2025. Verfasst von Kazuya Kusama und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine Pharmacology, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan. Hauptthemen laut MEDLINE: Stromal Cells, Endometrium, Dinoprostone, Thrombin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported by the Japan Society for the Promotion of Science., Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometriosis is hypothesized to result from retrograde menstruation where cell debris including endometrial stromal cells (ESCs) travel through the fallopian tubes. This chronic inflammatory disease is characterized by inflammatory and fibrotic endometrial tissue. We have previously observed reduced expression of the anti‐inflammatory factor SERPINA1 in endometriosis‐like lesions in a mouse model implanted with human ESCs. Additionally, pro‐inflammatory factors present in peritoneal hemorrhage exacerbated inflammation in these grafts, partly through prostaglandin (PG) E2 and thrombin. However, it remains unclear whether the reduction of SERPINA1, in combination with PGE2 and thrombin, synergistically influences the expression of inflammatory factors in endometriosis lesions and the underlying mechanisms. We analyzed RNA sequencing data from ESCs treated with SERPINA1 siRNA and PGE2/thrombin, comparing them to data sets derived from ESCs subjected to either SERPINA1 knockdown or PGE2/thrombin treatment. Comparative analysis identified 49 transcripts that were upregulated under both conditions and enriched for transcription regulatory genes, including SNAI1, HDAC5, PBX1, SOX4, EPAS1, LHX9, and MAFK. Silencing SNAI1, HDAC5, SOX4, EPAS1, or LHX9 suppressed IL6, CXCL8, and IL1B expression, which had been upregulated by SERPINA1 siRNA and PGE2/thrombin. Among these genes, LHX9 expression was significantly elevated in ectopic lesions, predominantly localized to stromal and glandular epithelial cells, with more pronounced expression during the secretory phase. LHX9 levels were also increased in endometriotic lesions compared to the normal endometrium. In conclusion, reduced SERPINA1 expression in ectopic ESCs, combined with PGE2/thrombin, induces inflammatory cytokine expression linked to LHX9. Pharmacological targeting of LHX9 may present a promising therapeutic strategy for mitigating chronic inflammation in endometriotic lesions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stromal CellsEndometriumDinoprostoneThrombinEndometriosisalpha 1-AntitrypsinInflammationTranscription FactorsFemaleHumansAnimalsMiceGene Silencing

Stichwörter der Autor:innen

LHX9SERPINA1endometrial stromal cellendometriosisprostaglandin E2thrombin

Substanzen

DinoprostoneThrombinalpha 1-AntitrypsinSERPINA1 protein, humanTranscription Factors

Autor:innen und Institutionen

  • Department of Endocrine Pharmacology, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
  • Department of Obstetrics and Gynecology, Tokyo Medical University, Tokyo, Japan.
  • Department of Obstetrics and Gynecology, Saitama Medical University, Saitama, Japan.

ORCID-Profile: Kazuya Kusama

Förderung

  • This study was supported by the Japan Society for the Promotion of Science.
  • Japan Society for the Promotion of Science

Zitieren

APA

Kusama, K., Ashihara, M., Okita, M., Yoshida, K., Suzuki, M., Suzuki, K., Hosokawa, R., Yoshie, M., Kojima, J., Mizuno, Y., Ono, M., Nishi, H., Kajihara, T., & Tamura, K. (2025). Role of Transcription Factor, LIM Homeobox 9 (LHX9) in Inflammatory Response by PGE2 and Thrombin in SERPINA1‐Silencing Endometrial Stromal Cells. Molecular Reproduction and Development. https://doi.org/10.1002/mrd.70046

Vancouver

Kusama K, Ashihara M, Okita M, Yoshida K, Suzuki M, Suzuki K, et al. Role of Transcription Factor, LIM Homeobox 9 (LHX9) in Inflammatory Response by PGE2 and Thrombin in SERPINA1‐Silencing Endometrial Stromal Cells. Molecular Reproduction and Development. 2025. doi:10.1002/mrd.70046

BibTeX
@article{Kusama2025,
  author = {Kusama, Kazuya and Ashihara, Misuzu and Okita, Moana and Yoshida, Kanoko and Suzuki, Masumi and Suzuki, Kaito and Hosokawa, Rena and Yoshie, Mikihiro and Kojima, Junya and Mizuno, Yumi and Ono, Masanori and Nishi, Hirotaka and Kajihara, Takeshi and Tamura, Kazuhiro},
  title = {Role of Transcription Factor, LIM Homeobox 9 (LHX9) in Inflammatory Response by PGE2 and Thrombin in SERPINA1‐Silencing Endometrial Stromal Cells},
  journal = {Molecular Reproduction and Development},
  year = {2025},
  doi = {10.1002/mrd.70046}
}
Kostenlos starten →